Stereotactic Radiosurgery With Abemaciclib, Ribociclib, or Palbociclib in Treating Patients With Hormone Receptor Positive Breast Cancer With Brain Metastases
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8|Metastatic Breast Carcinoma|Metastatic Malignant Neoplasm in the Brain|Prognostic Stage IV Breast Cancer AJCC v8
Interventions: DRUG: Abemaciclib|DRUG: Palbociclib|OTHER: Quality-of-Life Assessment|DRUG: Ribociclib
Sponsor: Emory University
Collaborators: National Cancer Institute (NCI)